S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

TLSA Tiziana Life Sciences Ltd

1.51

0.08 (5.59%)

Last Updated: 12:06:06

Delayed by 15 minutes

This Biotech Found Significant Success Following Key Announcement

A New York-based biotech company is stealing the mid-week show after it announced the broadening of its Phase 2 clinical trial for non-active secondary progressive multiple...

To read the full story on AllPennyStocks.com, click here.

Tiziana Life Sciences (NASDAQ:TLSA)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Tiziana Life Sciences Charts.

Tiziana Life Sciences (NASDAQ:TLSA)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Tiziana Life Sciences Charts.

Tiziana Life Sciences Ltd News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 4 March 2025 (1 week ago) • Edgar (US Regulatory)

Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial
Tuesday 4 March 2025 (1 week ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 27 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive Results for Nasal Anti-CD3 Therapy in Traumatic Brain Injury
Thursday 27 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 25 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter
Tuesday 25 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 21 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC
Friday 21 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 18 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program
Tuesday 18 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 11 February 2025 (1 month ago) • Edgar (US Regulatory)

Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer’s Disease
Tuesday 11 February 2025 (1 month ago) • GlobeNewswire Inc.

More Tiziana Life Sciences Ltd News Articles

Bnp Paribas Issuance

Leonteq Securities

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions